The Hidden Revenue Stream Boosting PT Outcomes by 23%: My Key Takeaways from APTA PPS 2024 & 2025

By Andrew Gorecki, PT, DPT, FAFS

If you attended the American Physical Therapy Association (APTA) Private Practice Section (PPS) Annual Conference, you know the conversation this year was dominated by one question: How do we survive declining reimbursements while maintaining quality care?

I had the privilege of speaking on this exact topic in my session, “Transforming PT Practices with Remote Therapeutic Monitoring for Better Outcomes & Profits.” (You can view the official 2025 agenda and session details here).

For those who couldn’t make it to the room, I want to share the “No-B.S. Roadmap” I presented—backed by real data from my own practice—on how Remote Therapeutic Monitoring (RTM) is saving private practices.

The Reality Check: Why We Need a Change

As practice owners, we are all feeling the squeeze. Cumulative Medicare reimbursement cuts have been relentless over the last decade. In my own practice, I watched our profit margin decline from a healthy 32% in 2019 to just 6% in 2022.

We faced a choice: increase patient volume to the point of burnout, or find a better way. We chose the latter. We introduced RTM in 2023, and the results were not just financial—they were clinical.

The Data: Improving Profits and Patients

In my presentation, I shared the exact numbers from Superior Physical Therapy to demonstrate that RTM is not just a billing code—it is a tool for clinical excellence.

1. Financial Turnaround By implementing a structured RTM program, we increased our profit margin from that low of 6% back up to 20% in 2023 and 2024.

• Without RTM: Our profit per case was roughly $91 – $104.
• With RTM: Our profit per case jumped to $362 – $393—an increase of 277%.

2. Clinical Outcomes The most common objection I hear is, “Does this actually help the patient?” The data says yes. We analyzed 2,223 patients using standardized tests like the NDI, DASH, and LEFS.

• Patients engaged in our RTM program saw their outcomes scores increase by 23% compared to those who did not.
• Our MIPS score hit a perfect 100 points in 2023 and 2024, securing us a significant payment adjustment.

The “No-B.S.” Roadmap to Success

During the session, I highlighted that simply buying software isn’t enough. In fact, 1.6% of Medicare patients are receiving RTM, which means most clinics are failing to implement it correctly.

Here are the biggest pitfalls I warned the APTA audience about:

• Dumping it on your clinical staff: Your PTs do not have an extra 60 minutes per month to monitor dashboards. This leads to burnout and failure.
• The “16-Day” Trap: Many software platforms fail to engage patients enough to capture the 16 days of data required to bill CPT code 98977.
• Lack of Personalization: Patients don’t engage with generic stick figures. They need personalized video engagement.

Why MovementRX is the best remote therapeutic monitoring software and service

We created MovementRX in 2018—years before the RTM codes existed—because we wanted better engagement for our patients. Because it was built by PTs for PTs, we offer two models: a “Do-It-Yourself” software for clinics with capacity, and a “Done-For-You” service where our team handles the monitoring.

As we look toward 2026 and potential new CPT codes, positioning your clinic with a robust RTM strategy is no longer optional. It is the key to surviving the current financial climate.

Ready to see how we did it? Check out my speaker profile and session on the APTA PPS website to verify the credentials, and then contact the MovementRX team to learn how we can replicate these results for your practice.